Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP325808.RA4ktjy-HckvbrDQSoVhqOuCYu6fawNi4ZBfjlLiWjqqg130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325808.RA4ktjy-HckvbrDQSoVhqOuCYu6fawNi4ZBfjlLiWjqqg130_provenance.
• NP442267.RA6cFDMRnsImOulXvxswKoJPrG6VoBN6_zNAMrIWNyNeg130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442267.RA6cFDMRnsImOulXvxswKoJPrG6VoBN6_zNAMrIWNyNeg130_provenance.
• NP936329.RAYeheViS9Q7ybGc4S7ih3IFFdNsf6nekpLQOESxtV81o130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936329.RAYeheViS9Q7ybGc4S7ih3IFFdNsf6nekpLQOESxtV81o130_provenance.
• NP581252.RAIFAsPn-Z_plxDH1ur1GkBwCzEGOazCn23OAiuA-zL9g130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP581252.RAIFAsPn-Z_plxDH1ur1GkBwCzEGOazCn23OAiuA-zL9g130_provenance.
• assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1078503.RAUsolVKAjNn3D-62Ax82tKM9u3fK0h4KR3DgKHZx-80o130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1078503.RAUsolVKAjNn3D-62Ax82tKM9u3fK0h4KR3DgKHZx-80o130_provenance.
• NP1078504.RAnEGn4I922FJsCVaO6Qum_61rlpXvv8ESTY_uh3leaOo130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1078504.RAnEGn4I922FJsCVaO6Qum_61rlpXvv8ESTY_uh3leaOo130_provenance.
• NP936332.RAG2Ao5wHP4uqwkfhxLS2iELACmdH-pzgIW1e0e7NfZrY130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936332.RAG2Ao5wHP4uqwkfhxLS2iELACmdH-pzgIW1e0e7NfZrY130_provenance.
• NP7515.RA_oVAeairE6H-ZF7jnTnc_YMiiVUGwbzqkMyCrr6rScY130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP7515.RA_oVAeairE6H-ZF7jnTnc_YMiiVUGwbzqkMyCrr6rScY130_provenance.
• NP936331.RA9pfmTACmmko4ylDqLCsCEkHl0iloWC1Pibvunc8Pv2M130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936331.RA9pfmTACmmko4ylDqLCsCEkHl0iloWC1Pibvunc8Pv2M130_provenance.
• NP1078502.RA3oS-qLy_kp88_GEqMSBLRxWdLaiBv1xIFUPHGwNwWnw130_assertion description "[Molecular modeling of FAM111A shows that residues affected by KCS and OCS mutations do not map close to the active site but are clustered on a segment of the protein and are at, or close to, its outer surface, suggesting that the pathogenesis involves the interaction with as yet unidentified partner proteins rather than impaired catalysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1078502.RA3oS-qLy_kp88_GEqMSBLRxWdLaiBv1xIFUPHGwNwWnw130_provenance.